Skip to main content
Browse by:
GROUP

Roivant Sciences Info Session

Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants - nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology.

We have built 15 Vants to date and have raised over $3 billion to pursue our mission. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson's disease, diabetes, sickle cell disease, and multiple rare and fatal pediatric conditions.

In addition to our biopharmaceutical subsidiaries, we also build technology-focused Vants focused on improving the process of developing and commercializing medicines.